Mostrar el registro sencillo del ítem

dc.contributor.authorMorales Pérez, Ingrid 
dc.contributor.authorGarcía Dopico, José
dc.contributor.authorGonzález Hernández, Tomás 
dc.contributor.authorGómez García, Isabel
dc.contributor.authorMilena Abril, Antonio
dc.contributor.authorObeso Inchausti, José
dc.contributor.authorRodríguez Díaz, Manuel
dc.contributor.otherCiencias Médicas Básicas
dc.contributor.otherGrupo de Neurobiología y Neurología Experimental.
dc.date.accessioned2024-07-29T20:08:22Z
dc.date.available2024-07-29T20:08:22Z
dc.date.issued2006
dc.identifier.urihttp://riull.ull.es/xmlui/handle/915/38598
dc.description.abstractPrevious studies have reported a high number of glycine (GLY) receptors in the substantia nigra (SN) but a low number of GLY-neurons, suggesting that taurine, a partial agonist of GLY-receptors, is the natural substrate for SN GLY-receptors. By using microdialysis to quantify amino acids in the extracellular space of the SN, we observed an extracellular pool of GLY in the rat that increased after depolarizing with high-Kþ in a Ca2þ-dependent manner and that diffuses through the extracellular space. GLY markedly increased after blocking either the tricarboxylic cycle with fluorocitrate or the glutamine synthetase activity with MSO. Because these products act selectively on glial cells, their effects show glia as a key cell in maintaining the extracellular pool of GLY in the SN. Extracellular GLY was modified by glutamate and glutamate receptor agonists. The local administration of GLY modified the extracellular concentration of GABA. Taken together, the complex regulation of the extracellular level of GLY, its possible glial origin and interaction with glutamate and GABA suggest a volume transmitter role for GLY in the SN, a possibility which also agrees with the recent finding of GLY-transporters in this centre.en
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.relation.ispartofseriesNeuropharmacology 50 (2006)
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.titleGlycine release in the substantia nigra: Interaction with glutamate and GABA.en
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.neuropharm.2005.10.014
dc.subject.keywordGlycineen
dc.subject.keywordGlutamateen
dc.subject.keywordGABAen
dc.subject.keywordZincen
dc.subject.keywordSubstantia nigra
dc.subject.keywordParkinson’s diseaseen


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • DCCMM. Ciencias Médicas Básicas
    Documentos de investigación (artículos, libros, capítulos de libros, ponencias...) publicados por investigadores del Departamento de Ciencias Médicas Básicas

Mostrar el registro sencillo del ítem